Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lazarus

Showing results (221-230 of 432) with videos related to

Pageof 44
Sort By:
HIV Medicine|September 3, 2010
Overcoming obstacles to late presentation for HIV infection in EuropeJ V Lazarus, R Jürgens, M Weait, et al.
Nature Reviews. Gastroenterology & Hepatology|June 8, 2023
Measuring NAFLD models of careAlina M Allen, Zobair M Younossi, Emmanuel A Tsochatzis, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 16, 2018
Hepatitis C prevalence among the migrant population in Spain: A systematic review and meta-analysisJeffrey V Lazarus, Daniel J Bromberg, Julia Del Amo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
JAMA Network Open|October 25, 2024
Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, SpainPablo Ryan, Jorge Valencia, Daniel Sepúlveda-Crespo, et al.
Open Forum Infectious Diseases|July 12, 2021
Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, SpainJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Diabetologia|May 21, 2026
MASLD prevalence, incidence and global aspectsSarah H Wild, Jeffrey V Lazarus, C Wendy Spearman, et al.
BMC Medicine|October 10, 2018
Pathways to ensure universal and affordable access to hepatitis C treatmentCaitlin H Douglass, Alisa Pedrana, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy|July 11, 2017
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responsesJ V Lazarus, K Safreed-Harmon, S R Stumo, et al.
BMC Health Services Research|May 8, 2015
Roundtable discussion on the Third Global Symposium on Health Systems Research: why prioritise talk over aid in the midst of the Ebola crisis?Jeffrey V Lazarus, Dina Balabanova, Kelly Safreed-Harmon, et al.
Pageof 44

Showing results (221-230 of 432) with videos related to

Sort By:
Pageof 44
HIV Medicine|September 3, 2010
Overcoming obstacles to late presentation for HIV infection in EuropeJ V Lazarus, R Jürgens, M Weait, et al.
Nature Reviews. Gastroenterology & Hepatology|June 8, 2023
Measuring NAFLD models of careAlina M Allen, Zobair M Younossi, Emmanuel A Tsochatzis, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 16, 2018
Hepatitis C prevalence among the migrant population in Spain: A systematic review and meta-analysisJeffrey V Lazarus, Daniel J Bromberg, Julia Del Amo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
JAMA Network Open|October 25, 2024
Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, SpainPablo Ryan, Jorge Valencia, Daniel Sepúlveda-Crespo, et al.
Open Forum Infectious Diseases|July 12, 2021
Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, SpainJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Diabetologia|May 21, 2026
MASLD prevalence, incidence and global aspectsSarah H Wild, Jeffrey V Lazarus, C Wendy Spearman, et al.
BMC Medicine|October 10, 2018
Pathways to ensure universal and affordable access to hepatitis C treatmentCaitlin H Douglass, Alisa Pedrana, Jeffrey V Lazarus, et al.
The International Journal on Drug Policy|July 11, 2017
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responsesJ V Lazarus, K Safreed-Harmon, S R Stumo, et al.
BMC Health Services Research|May 8, 2015
Roundtable discussion on the Third Global Symposium on Health Systems Research: why prioritise talk over aid in the midst of the Ebola crisis?Jeffrey V Lazarus, Dina Balabanova, Kelly Safreed-Harmon, et al.
Pageof 44